title: Repeat Associated Non-AUG Translation (RAN Translation) Dependent on Sequence Downstream of the ATXN2 CAG Repeat.
abstract: Spinocerebellar ataxia type 2 (SCA2) is a progressive autosomal dominant disorder caused by the expansion of a CAG tract in the ATXN2 gene. The SCA2 disease phenotype is characterized by cerebellar atrophy, gait ataxia, and slow saccades. ATXN2 mutation causes gains of toxic and normal functions of the ATXN2 gene product, ataxin-2, and abnormally slow Purkinje cell firing frequency. Previously we investigated features of ATXN2 controlling expression and noted expression differences for ATXN2 constructs with varying CAG lengths, suggestive of repeat associated non-AUG translation (RAN translation). To determine whether RAN translation occurs for ATXN2 we assembled various ATXN2 constructs with ATXN2 tagged by luciferase, HA or FLAG tags, driven by the CMV promoter or the ATXN2 promoter. Luciferase expression from ATXN2-luciferase constructs lacking the ATXN2 start codon was weak vs AUG translation, regardless of promoter type, and did not increase with longer CAG repeat lengths. RAN translation was detected on western blots by the anti-polyglutamine antibody 1C2 for constructs driven by the CMV promoter but not the ATXN2 promoter, and was weaker than AUG translation. Strong RAN translation was also observed when driving the ATXN2 sequence with the CMV promoter with ATXN2 sequence downstream of the CAG repeat truncated to 18 bp in the polyglutamine frame but not in the polyserine or polyalanine frames. Our data demonstrate that ATXN2 RAN translation is weak compared to AUG translation and is dependent on ATXN2 sequences flanking the CAG repeat.
authors.affiliation: Department of Neurology, University of Utah, 175 North Medical Drive East, 5th Floor, Salt Lake City, Utah, 84132, United States of America.
authors.forename: Daniel R
authors.initials: DR
authors.lastname: Scoles
authors.affiliation: Department of Neurology, University of Utah, 175 North Medical Drive East, 5th Floor, Salt Lake City, Utah, 84132, United States of America.
authors.forename: Mi H T
authors.initials: MH
authors.lastname: Ho
authors.affiliation: Department of Neurology, University of Utah, 175 North Medical Drive East, 5th Floor, Salt Lake City, Utah, 84132, United States of America.
authors.forename: Warunee
authors.initials: W
authors.lastname: Dansithong
authors.affiliation: Department of Neurology, University of Utah, 175 North Medical Drive East, 5th Floor, Salt Lake City, Utah, 84132, United States of America.
authors.forename: Lance T
authors.initials: LT
authors.lastname: Pflieger
authors.affiliation: Department of Neurology, University of Utah, 175 North Medical Drive East, 5th Floor, Salt Lake City, Utah, 84132, United States of America.
authors.forename: Lance W
authors.initials: LW
authors.lastname: Petersen
authors.affiliation: Department of Neurology, University of Utah, 175 North Medical Drive East, 5th Floor, Salt Lake City, Utah, 84132, United States of America.
authors.forename: Khanh K
authors.initials: KK
authors.lastname: Thai
authors.affiliation: Department of Neurology, University of Utah, 175 North Medical Drive East, 5th Floor, Salt Lake City, Utah, 84132, United States of America.
authors.forename: Stefan M
authors.initials: SM
authors.lastname: Pulst
mesh_terms: D000067698:Ataxin-2 / Q000235:genetics* / Q000502:physiology; D057809:HEK293 Cells; D006801:Humans; D008156:Luciferases / Q000378:metabolism; D011401:Promoter Regions, Genetic / Q000235:genetics / Q000502:physiology; D060888:Real-Time Polymerase Chain Reaction; D020754:Spinocerebellar Ataxias / Q000235:genetics; D019680:Trinucleotide Repeat Expansion / Q000235:genetics* / Q000502:physiology
chemical_list: C000593752:ATXN2 protein, human; D000067698:Ataxin-2; D008156:Luciferases